A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients
Clinical trial NCT05680155 · COMPLETED
Trial details
- NCT number
- NCT05680155
- Sponsor
- Hangzhou Sciwind Biosciences Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-29
- Primary completion
- 2024-06-12
- Enrollment
- 211
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.